QPharma

QPharma is a specialised CDMO focused on controlled release systems for highly potent drugs up to OEB6, providing end-to-end development and manufacturing services. The company's expertise encompasses the development of new products across various stages and the manufacturing of commercial products, serving clients across Europe, the United States, and other global markets. 

QPharma also specialises in polymer-based sustained release dosage forms such as Vaginal rings and cytotoxic, hormonal and ocular implants/inserts, Aseptic Fill and Finish/Prefilled Syringes and Autoinjector Assembly, and Hot Melt Extrusion as a solubility enhancement solution for poorly soluble drugs. Its R&D expertise centers on polymer-based delivery systems, using versatile technology platforms and advanced modeling algorithms to transform pharmaceutical ideas into viable products. The company combines high-potent drug development experience with global GMP compliance and robust manufacturing capabilities. 

QPharma’s manufacturing is primarily based in Malmö, Sweden. In 2021 the US company Foster Delivery Science was acquired which included a site in Putnam, CT, USA providing us with extended R&D and manufacturing capabilities. 

ADDRESS
Agneslundsvägen 27, 212 15 Malmö, Sweden 

CONTACT
Ulrike (Uli) Foley
Head of Global Business Development and Marketing
ufoley@qpharma.com, +1 203-918-1659

WEBSITE
www.qpharma.com